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Human leukocyte antigen (HLA) class I and class II alleles are implicated as genetic risk factors formany autoimmune
diseases. However, the role of the HLA loci in human systemic lupus erythematosus (SLE) remains unclear. Using
a dense map of polymorphic microsatellites across the HLA region in a large collection of families with SLE, we
identified three distinct haplotypes that encompassed the class II region and exhibited transmission distortion.DRB1
and DQB1 typing of founders showed that the three haplotypes contained DRB1*1501/DQB1*0602,DRB1*0801/
DQB1*0402, and DRB1*0301/DQB1*0201 alleles, respectively. By visualizing ancestral recombinants, we nar-
rowed the disease-associated haplotypes containing DRB1*1501 and DRB1*0801 to an ∼500-kb region. We con-
clude that HLA class II haplotypes containing DRB1 and DQB1 alleles are strong risk factors for human SLE.
Introduction
The human leukocyte antigen (HLA) region on human
chromosome 6p21.3 spans ∼3.6 Mb of DNA and con-
tains 1200 genes, many of which have important roles
in the immune system (Aguado et al. 1999; Dawkins et
al. 1999; Rhodes and Trowsdale 1999). The HLA region
can be divided roughly into thirds. The telomeric class
I region contains the polymorphic HLA A, B, and C
genes, which are expressed ubiquitously and function to
present antigenic peptides to CD8 cytotoxic T cells.
The centromeric class II region encodes the polymorphic
DR, DQ, and DP genes, which are expressed on “pro-
fessional” antigen-presenting cells and serve to display
peptides to CD4 helper T cells. The class II region also
contains genes important for antigen processing, includ-
ing the TAP, LMP, and DM genes. The class III region
lies between the class I and II regions and contains genes
important for the innate immune system, including the
cytokine tumor necrosis factor a and the complement
components C2 and C4. There are also many genes
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within the HLA region with no obvious function in the
immune system.
In addition to their role in determining transplantation
tolerance (Snell 1948), HLA class I and II alleles show
genetic associations with certain inflammatory and au-
toimmune disorders (reviewed by Vyse and Todd [1996]).
Examples include the association of class I HLA B27 with
ankylosing spondylitis and of HLA Cw6 with psoriasis,
as well as the association of class II DRB1*0401 (DR4)
with rheumatoid arthritis, DRB1*1501 (DR2) with
multiple sclerosis, and both DRB1*0301 (DR3) and
DRB1*0401 (DR4) with type I diabetes. Because of ex-
tensive linkage disequilibrium across the HLA region, it
has often been difficult to determine whether the observed
associations reflect the class I or class II alleles themselves,
linked genes, or combinations of genes carried on a par-
ticular haplotype. This difficulty is exemplified by recent
data indicating that the long-standing association of pso-
riasis with HLA-Cw6 is due to the effect of a gene closely
linked with, but separate from, the HLA-C loci (Nair et
al. 2000).
Systemic lupus erythematosus (SLE [MIM 152700]) is
a chronic and severe inflammatory autoimmune disease
that affects mostly women (∼10:1 female-to-male ratio).
A prominent feature of SLE is the production of path-
ogenic autoantibodies with specificity for nuclear and
other tissue antigens. These autoantibodies lead to tissue
damage by depositing in blood vessels as immune com-
plexes and by initiating inflammatory responses after
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binding to self-antigens. SLE is clinically very heteroge-
neous and has the potential to affect many different organ
systems. There is compelling epidemiological evidence to
suggest an important genetic contribution to human SLE
(Hochberg 1997), and recent genetic linkage studies in
human families with lupus have identified candidate sus-
ceptibility loci at 1q23, 1q41-2, 2q37, 4p15, 6p11, and
16q12 (reviewed by Wakeland et al. [2001] and Gaffney
et al. [2002]).
Previous case/control association studies have exam-
ined the potential role of HLA class I and II alleles in
genetic susceptibility to SLE (Harley et al. 1998; Tan
and Arnett 1998). The most consistent findings have
been modest associations of DRB1*1501 (DR2) and
DRB1*0301 (DR3) alleles in white individuals with SLE.
However, these associations have, on balance, been much
less convincing than those observed in rheumatoid ar-
thritis (DR4) or type I diabetes (DR3). Furthermore, SLE
class II associations in nonwhite ethnic groups have
shown little consensus.
Here, we present the results of dense HLA micro-
satellite mapping in a collection of 334 families with
SLE. Three risk haplotypes, bearing the class II alleles
DRB1*1501/DQB1*0602, DRB1*0301/DQB1*0201,
and DRB1*0801/DQB1*0402, were found to exhibit
significant transmission distortion in families with SLE
and were enriched in individuals with SLE, compared
with control individuals. Through visualization of an-
cestral recombinants, the risk region on each haplotype
was localized to defined intervals. The identification of
SLE-associated HLA haplotypes and the localization of
the effect to discrete risk intervals should facilitate the
search for the genes and polymorphisms responsible for
mediating susceptibility to SLE.
Material and Methods
Collection of Families with SLE
The demographic and clinical features of the 576 af-
fected individuals (566 female and 10 male) from 211
affected sib-pair and 123 simplex families are described
in detail elsewhere (Gaffney et al. 1998, 2000; Graham
et al. 2001). All patients fulfilled American College of
Rheumatology criteria for SLE. There were 283 white,
22 African American, and 15 Hispanic families, together
with 14 families of other/mixed ethnicity. This study was
approved by the Human Subjects Review Board at the
University of Minnesota.
Samples and Genotyping
Genotyping was performed as described by Gaffney et
al. (2000) and Graham et al. (2001). A total of 106 mi-
crosatellite markers spanning chromosome 6 were typed
in 187 sib-pair families, and 52 HLA markers were typed
in the combined 334-family collection (1,121 total sam-
ples). Of the markers used to map the HLA, 31 have been
described elsewhere (Nair et al. 2000). Fifteen new mark-
ers were developed from primary sequence during the
course of this project (see supplementary material at the
Behrens Lab Web site, for detailed marker information,
as well as Jawaheer et al. 2002 [in this issue]). Marker
order and intermarker distances were determined from
the Human Genome Project Working Draft (UCSC Ge-
nome Bioinformatics Web site) and the Current Consen-
sus MHC sequence (Sanger Institute: Human Chromo-
some 6 Home Web site). HLA-DRB1 and HLA-DQB1
alleles were typed in 208 founders carrying one or more
of the risk haplotypes; typing was performed as described
by Erlich et al. (1991). After confirming that the
D6S2666/2665/2446 haplotype was essentially 100% ac-
curate in predicting the underlying DRB1 and DQB1 risk
alleles, we made DR and DQ assignments on the basis of
the three-marker microsatellite haplotype.
Data Analysis
All genotyping data were analyzed by PEDCHECK to
identify any genotyping/Mendelian errors (O’Connell and
Weeks 1998). Linkage analysis was performed using the
“maximum likelihood estimate of IBD sharing” function
of GENEHUNTER PLUS (Kong and Cox 1997). Asso-
ciation analysis was performed using either the pedigree
disequilibrium test (PDT) (PDT version 2.0 [Martin et al.
2000], modified to analyze dyads when triads are una-
vailable) or the transmission/disequilibrium test (TDT)
(TDT/S-TDT version 1.1 [Spielman et al. 1993; Spielman
and Ewens 1998]). When the TDT was used, a single
affected individual (the index case individual) per family
was analyzed in families with multiple affected individuals
and/or multiple generations. For association studies, hap-
lotype frequencies were determined from the index case
individual of each white family with SLE and from a
collection of 174 unrelated female white control individ-
uals. Control individuals were recruited in the New York
metropolitan area as part of an ongoing longitudinal co-
hort study, the New York Cancer Project, administered
by the Academic Medicine Development Corporation
(AMDeC). The ethnic background of each control indi-
vidual was established by obtaining information on the
origin of all four grandparents. The genotypic relative risk
(GRR) was calculated as described by Risch and Meri-
kangas (1996).
Haplotypes across the HLA were generated by GENE-
HUNTER PLUS for the 275 families that had at least one
typed parent. Short exact-match haplotypes were assigned
a unique identifying number, and pedigree files were gen-
erated for PDT or TDT analyses. Inferred haplotypes
(constructed for “missing” parents as determined by
transmission data) were not used for association analyses
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but were used to assist in the determination of ancestral
haplotypes and ancestral recombinant breakpoints. Ex-
tended haplotype analysis was conducted by first identi-
fying the consensus extended haplotype for each of the
three class II risk haplotypes identified by the PDT. This
was determined on the basis of allele frequencies of neigh-
boring markers. The consensus microsatellite allele for
each founder haplotype was then color-coded maroon.
Gold denotes nonconsensus alleles, and gray represents
missing data or a genotype with ambiguous phase. The
risk founder haplotypes were then sorted on the basis of
the number of contiguous consensus alleles (allowing for
one marker deviation) radiating from the marker used to
select the founder haplotypes in either the telomeric or
centromeric direction. Risk haplotypes were then subdi-
vided on the basis of length and composition of consensus
alleles and were analyzed using the TDT and PDT. For
additional details, see the supplementary material at the
Behrens Lab Web site.
Results
Our recent gene mapping in 187 sib-pair families with
SLE identified a LOD score of 4.19 on the short arm of
human chromosome 6 (Gaffney et al. 1998, 2000). After
genotyping of an additional 31 microsatellite markers
across 6p (with an average intermarker distance of 2
Mb), including 6 markers within the HLA, the strongest
evidence for allele sharing by affected siblings was within
the HLA (data not shown).
Single-Marker Family-Based Association Analysis
Using the PDT, a multiallelic test robust for complex
pedigrees (Martin et al. 2000), we found that marker
D6S2446 in the class II region showed the strongest
evidence for association ( ; fig. 1A). Inter-4Pp 9# 10
estingly, this marker is located in the 75-kb interval be-
tween the highly polymorphic DRB1 and DQB1 genes
(see online-only figure). To extend these findings, we
genotyped the original cohort of 187 families, including
an additional 34 sib-pair families, with a dense panel of
microsatellite markers across the HLA region (with an
average intermarker distance 62 kb; see online-only fig-
ure). When the PDT was used, the strongest evidence
for association was again found in the class II region at
D6S2446 ( ; fig. 1B).5Pp 4# 10
The same marker panel was then applied to an inde-
pendent sample of 123 simplex families (single patient
with SLE and both parents). Again, the best evidence for
association in the simplex collection was at D6S2446
( ; fig. 1B). The results of the PDT at3Pp 2# 10
D6S2446 for the combined collection of sib-pair and sim-
plex pedigrees (a total of 334 families) was highly sig-
nificant ( ; fig. 1B). Other regions showed8Pp 3# 10
some evidence for association (e.g., ∼1.0 and 2.1 Mb);
however, these signals are likely the result of linkage dis-
equilibrium, since the evidence for association at these
markers was not observed independent of the class II risk
haplotypes (figs. 2 and 3, and data not shown).
Identification of Risk Haplotypes
To determine whether the observed effect was due to
a single or multiple risk haplotypes, the individual alleles
of D6S2446 and short haplotypes containing this marker
were examined for association in the combined data set.
Three individual alleles of D6S2446 (alleles 6, 8, and
5) showed significant transmission disequilibrium, and
multimarker haplotypes containing these alleles dem-
onstrated even higher levels of disequilibrium (table 1).
We next stratified the families with SLE by ethnicity. The
risk haplotypes were found primarily in the white fam-
ilies and were rare in the nonwhite families (table 1).
None of the haplotypes common to nonwhite families
demonstrated significant disease association (data not
shown); however, the current family collection has lim-
ited power to address this issue.
DRB1 and DQB1 PCR/SSO (sequence-specific oli-
gonucleotide) typing of founders carrying one of
the risk alleles at D6S2446 revealed that the three
risk haplotypes contained DRB1*1501/DQB1*0602
(DR2/DQ6), DRB1*0301/DQB1*0201 (DR3/DQ2),
and DRB1*0801/DQB1*0402 (DR8/DQ4) (table 1).
DNA sequencing of genes tightly linked to DRB1 con-
firmed that the microsatellite haplotypes faithfully iden-
tified ancestral fragments of DNA that were identi-
cal between unrelated founders bearing the haplotype
(R.R.G., P.K.G., and T.W.B., unpublished data).
Of interest, families carrying one or more of the iden-
tified risk haplotypes accounted for nearly all of the trans-
mission disequilibrium observed in the class II region
across the entire family collection (D6S2446; PDT Pp
) (fig. 1C). Conversely, the 84 families lacking71# 10
any of the identified class II risk haplotypes showed no
disequilibrium at D6S2446 by PDT analysis ( ).Pp .50
The sib-pair pedigrees within this group ( ) alsonp 47
showed no evidence for linkage in the HLA region
( at D6S2662). We conclude that there areLODp 0.17
three HLA risk haplotypes in our family collection, with
the strongest evidence for transmission disequilibrium in
the class II region at D6S2446.
Visualization of Ancestral Recombinant Class II Risk
Haplotypes
To visualize the recombinant class II–containing risk
haplotypes, we first examined all founder haplotypes
containing allele 6 at D6S2446 (D6S2446-6; fig. 2). The
consensus allele for each marker on the extended hap-
lotype was determined (see the “Material and Methods”
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Figure 1 Association between the HLA class II region and SLE. A, PDT global association results for 55 markers across the length of
chromosome 6 in 187 sib-pair families with SLE. B, PDT results for 41 HLA markers in 211 multiplex families (unfilled triangles), 123 simplex
families (unfilled circles), and all 334 families (filled circles). The heterozygosity index for each marker was 10.70. C, PDT association results
in 275 families (filled circles), where at least one parent was available and where phase could be determined unambiguously. Of these, 191
families carried at least one of the three risk haplotypes (unfilled circles), whereas 84 families lacked a risk haplotype (unfilled triangles). The
position of selected HLA genes are indicated by the arrows. Dashed lines indicate .Pp .05
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Figure 2 Visualization of founder risk haplotypes carrying DRB1*1501 (DR2). Shown are all founder haplotypes carrying allele 6 at
marker D6S2446 (D6S2446-6). The consensus ancestral haplotype containing D6S2446-6 was determined, and individual alleles were color-
coded: marker alleles identical to consensus are shown in maroon, alleles different from consensus are shown in gold, and missing data or
alleles with ambiguous phase are shown in gray. After sorting by length, groups of founder haplotypes were tested by TDT, with the numbers
shown referring to the ratio of T:NT haplotypes. Blue boxes indicate significant transmission distortion ( ) for the larger groups; whiteP ! .05
boxes indicate nonsignificant TDTs. A, Founder haplotypes ( ) were sorted by telomeric (left) length, and TDTs were performed. B,Np 176
Founder haplotypes ( ) were sorted, first by centromeric (right), and then by telomeric (left) length, to define the centromeric “breakpoint”Np 176
by TDT. C, Founder haplotypes ( ) carrying the TNF-a allele found on the DRB1*1501 extended haplotype were sorted on the basisNp 155
of centromeric (right) length. Only those haplotypes extending to DRB1/DQB1 were significant by TDT. At the bottom of panel C are four
“double recombinant” haplotypes, showing consensus markers for the TNF and class II regions but showing nonconsensus in-between; T:NT
ratio is 3:1. Asterisks (*) represent the approximate boundaries of the haplotype length showing convincing evidence for transmission distortion.
Haplotype groupings that failed to show significant transmission disequilibrium (white boxes) did not contain DRB1*1501, despite carrying
D6S2446-6.
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Figure 3 Haplotypes containing DRB1*0301 (DR3) and DRB1*0801 (DR8) show significant transmission disequilibrium in families with
SLE. Founder haplotypes were sorted and analyzed as described in figure 2. A and B, Founder haplotypes ( ) carrying D6S2446-8Np 110
(DRB1*0301 linked) were sorted on the basis of telomeric (left) length (A), and centromeric (right) length (B). C, Founder haplotypes (Np
) carrying D6S2446-5 (DRB1*0801 linked) sorted on the basis of overall length. Asterisks (*) represent the approximate boundaries of the68
haplotypes showing convincing evidence for transmission distortion. Haplotypes that failed to show significant transmission disequilibrium
(white boxes) did not contain DRB1*0301 or DRB1*0801, despite carrying D6S2446-8 (A and B) or D6S2446-5 (C), respectively.
section), and founder haplotypes were color-coded, with
maroon indicating an exact match with consensus and
with gold denoting a difference from consensus. Missing
data or alleles with ambiguous phase are highlighted in
gray.
The D6S2446-6 founder haplotypes were first sorted
on the basis of the number of contiguous marker alleles
identical to the consensus extended haplotype (fig.
2A). This revealed multiple ancestral recombinant
DRB1*1501-containing haplotypes (with the size of the
recombinant haplotypes decreasing from top to bottom
in fig. 2A). Haplotypes were then grouped on the basis
of length, and each group was tested for association, using
the TDT (Spielman et al. 1993; Spielman and Ewens
1998) and PDT (data not shown). Haplotype clusters
showing overall significant transmission distortion are
highlighted in blue (right side of the panel). The group of
short recombinant haplotypes having a 22:11 transmit-
ted:not transmitted (T:NT) ratio suggested a telomeric
ancestral recombinant “breakpoint” at approximately
marker MN6S2468 (marked by the left asterisk in fig. 2).
To determine the location of the centromeric ancestral
“breakpoint,” the founder haplotypes were again sorted,
first by identity centromeric to D6S2446 and then by
extent of telomeric identity (fig. 2B). This demonstrated
that founder haplotypes extending centromeric to marker
MN6S2944 (right asterisk in fig. 2) had a level of trans-
mission distortion similar to that of haplotypes that ex-
tended beyond. Thus, the estimated centromeric “break-
point” on this haplotype is ∼60 kb centromeric of
DQB1 (∼66 kb centromeric of D6S2446), near marker
MN6S2944, a known recombination hotspot within the
HLA region (Jeffreys et al. 2001).
Recent studies have suggested that certain tumor-necro-
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Table 2
Frequency of Class II Risk Haplotypes in White Patients with SLE and Control Individuals
RISK HAPLOTYPEa
FREQUENCY
(%)
P VALUEb
GRRc
Patient
(Np 560
chromosomes)d
Control
(Np 348
chromosomes)e Heterozygote Homozygote
DRB1*1501/DQB1*0602 20.7 12.3 .0012 1.9 3.5
DRB1*0301/DQB1*0201 17.3 7.5 2.7#105 2.6 6.7
DRB1*0801/DQB1*0402 3.6 1.7 NS (.09) 2.2 4.7
Any of the risk haplotypes 41.6 21.5 4.7#1010 2.6 6.8
a Haplotypes containing the indicated DRB1/DQB1 molecules were determined by microsatellite genotypes
for markers D6S2666/2665/2446.
b Determined by x2 analysis. NS p not significant.
c Calculated as described by Risch and Merikangas (1996).
d Index case individuals from white families with SLE.
e Unrelated white female control individuals.
sis factor (TNF)–a alleles may contribute to SLE (Rood
et al. 2000). To determine whether TNF alleles on the
DRB1*1501 haplotype were important for the observed
effect, we selected all founder haplotypes that contained
the consensus TNF allele from the DRB1*1501 extended
haplotype and then sorted and analyzed the data. Strik-
ingly, founder haplotypes carrying the consensus TNF re-
gion showed disequilibrium only if they also included
DRB1*1501 and DQB1*0602 of the extended haplotype
(fig. 2C). Recombinant founder haplotypes that excluded
the DRB1*1501 class II region failed to show risk. We
suggest that the region of interest on the extended
DRB1*1501 haplotype contains both the DRB1 and
DQB1 genes and effectively excludes the class I and III
regions, including TNF-a.
Founder haplotypes that contained allele 8 at D6S2446
(in strong linkage disequilibrium with DRB1*0301) were
then analyzed using the same strategy (fig. 3A and 3B).
On the basis of the visualized ancestral haplotypes, it was
clear that the level of linkage disequilibrium of markers
on this haplotype was much higher than was observed
for the DRB1*1501 haplotype (compare with fig. 2). HLA
A, B, and C typing confirmed that this haplotype cor-
responds to the HLA A1-B8-DR3 haplotype, which is
known to have unusually extensive disequilibrium (Daw-
kins et al. 1999). The microsatellites used could distin-
guish the northern European B8-DR3 haplotype from
the southern European B18-DR3 haplotype, which was
found in only 1.3% of the founders in the study and
showed no association with disease (data not shown).
Because of the relative paucity of ancestral recombi-
nants, the risk region within DRB1*0301-containing
haplotypes could not be narrowed beyond an ∼1 Mb
region encompassing most of the class III and class II
regions.
Consensus alleles for the extended ancestral haplotype
carrying DRB1*0801 could be identified up to only the
class I/class III boundary (fig. 3C). Haplotypes contain-
ing DRB1*0801 were less common in our family col-
lection, and ancestral recombinants allowed the risk in-
terval to be narrowed to region of ∼500 kb between
markers D6S2669 and D6S2662.
Haplotype Frequencies in SLE Case and Control
Individuals
The three SLE class II risk haplotypes were highly
enriched in white families. Of the 254 families carrying
one or more of the risk haplotypes, 229 (90%) were
white or had known white admixture. To explore this
further, we compared allele frequencies of 280 female
white SLE index case individuals from the family col-
lection and 174 female white control individuals for the
identified D6S2666/2665/2446 risk haplotypes (tables 2
and 3). As shown in table 2, the risk haplotypes were
more common on the chromosomes of patients with SLE
than in control individuals, with an approximately two-
fold increase in risk haplotype frequency. GRR calcu-
lations indicated a doubling of risk for homozygotes
(table 2), consistent with an additive model for genet-
ic risk of these haplotypes (Risch and Merikangas
1996). A similar picture emerged when the status of het-
erozygosity and homozygosity for the various risk hap-
lotypes was examined (table 3). In these analyses,
DRB1*0301-containing haplotypes conferred the high-
est degree of risk, followed by DRB1*1501-containing
haplotypes and then DRB1*0801-containing haploty-
pes. The case/control data for the DRB1*0801 haplo-
types trended toward, but did not reach, significance
with the current sample size. Given that the TDT results
for DRB1*0801-containing haplotypes were significant
(table 1), this suggests an improved ability of the TDT
to detect association for the relatively rare DRB1*0801
class II haplotype, compared with the case/control ap-
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Table 3
Dose-Dependent Risk from Class II Susceptibility Haplotypes
RISK HAPLOTYPEa
FREQUENCY IN
(%)
P VALUEb
RELATIVE
RISKc
Patientsd
( )Np 280
Control
Individualse
( )Np 174
DRB1*1501/DQB1*0602:
Heterozygote 33.6 22.4 .0110 1.5
Homozygote 3.9 1.1 NS (.084) 3.5
DRB1*0301/DQB1*0201:
Heterozygote 29.6 12.6 3.0#105 2.3
Homozygote 2.5 1.1 NS (.32) 2.3
DRB1*0801/DQB1*0402:
Heterozygote 6.4 3.4 NS (.17) 1.9
Homozygote .4 .0 NS (.43) …
Heterozygote for 1 of 3 risk haplotypes 45.0 33.9 .0190 1.3
Compound heterozygote 12.1 2.3 2.3#104 5.2
Simple homozygote 6.8 2.3 .0340 3.0
Any haplotype combination 63.9 38.5 1.3#107 1.7
a Haplotypes containing the indicated DRB1/DQB1 molecules were determined by microsat-
ellite genotypes for markers D6S2666/2665/2446
b Determined by x2 analysis. NS p not significant.
c Calculated as frequency in patients with SLE/frequency in control individuals.
d Index case individuals from white families with SLE.
e Unrelated white female control individuals.
proach. Finally, it was striking that nearly two-thirds
(63.9%) of the patients carried at least one of the risk
haplotypes. We conclude that the identified class II risk
haplotypes are enriched in SLE patients and show strong
association in a case-control study design.
Discussion
In the present article, we describe a haplotype-based ap-
proach to identify and narrow the HLA risk intervals in
a collection of 334 sib-pair and simplex families with
SLE. Related approaches have recently been used to dis-
sect the role of HLA alleles in several other autoimmune
disorders, including type 1 diabetes (Koeleman et al.
2000; Zavattari et al. 2001), psoriasis (Oka et al. 1999;
Nair et al. 2000), Behcet disease (Ota et al. 1999), mul-
tiple sclerosis (Marrosu et al. 2001), and rheumatoid
arthritis (Jawaheer et al. 2002 [in this issue]). The dense
map of microsatellite markers that were typed across the
HLA allowed us to reconstruct and then visualize the
ancestral DNA haplotypes carrying these risk alleles. For
this approach to be successful, it was important that
most of the markers maintained stable repeat lengths
over long periods of human population history and
therefore could be used to identify the underlying an-
cestral DNA haplotypes with fidelity. This was indeed
the case. Sequencing of unrelated individuals carrying
the various marker haplotypes showed essentially no se-
quence diversity at the nucleotide level (R.R.G., P.K.G.,
and T.W.B., unpublished data). These data show that it
is possible to type patients for certain class II DRB1 and
DQB1 alleles solely on the basis of their D6S2666/2665/
2446 marker haplotype.
Through visualization of recombinations on the an-
cestral haplotypes carrying the alleles DRB1*1501 and
DRB1*0801, the risk regions on these haplotypes could
be narrowed to an ∼500-kb region containing both
DRB1 and DQB1. The only other genes in this interval
are two genes of unknown function—chromosome 6
ORF 10 (C6orf10, formerly known as “testis specific
basic protein”) and butyrophilin-like family member II
(BTNL2)—together with DRA (invariant), DRB3
and DRB5 (additional b-chain genes present on the
DRB1*0301 and DRB1*1501 haplotypes, respectively),
and DQA (a different allele for each of the risk haplo-
types). Sequencing of these genes on the various risk hap-
lotypes should allow us to determine whether the genetic
effect in this region is limited to the class II DRB1, DQA1,
and/or DQB1 genes, or whether it includes other tightly
linked genes, possibly acting in epistasis. In the future,
we will attempt to further narrow the regions of interest
by identifying additional families with SLE that carry
short recombinant risk haplotypes.
The extensive disequilibrium of the DRB1*0301 hap-
lotype severely limits the ability to localize the genetic
effect on this haplotype. It is important to note that the
TNF-a and C4 “null” alleles, which have previously
been suggested as risk factors for SLE (Harley et al.
1998; Tan and Arnett 1998), are both carried on the
extended A1/B8/DR3 haplotype. These data suggest
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that caution should be exercised before assigning risk
to any individual gene on the DRB1*0301 haplotype,
given the extensive disequilibrium observed. On the ba-
sis of the finding that the DR2- and DR8-containing
risk haplotypes exclude most, if not all, of the class I
and III regions, we hypothesize that the major genetic
effect on the DR3 haplotype may be similarly localized
to the class II region. However, we cannot rule out the
possibility that other genes on the extended haplotype
may also be contributing to risk.
The hypothesis that class II–containing haplotypes
are major genetic risk factors in human SLE is supported
by studies in the mouse (Morel et al. 1994; Vyse and
Kotzin 1998) and has important implications for un-
derstanding the pathogenesis of SLE. Previous studies
have suggested that the autoimmune response in SLE is
driven by antigen, with extensive somatic hypermuta-
tion observed in B cells from mice and humans with
lupus (Diamond et al. 1992). Somatic hypermutation
requires CD4 helper T cells, which are activated by
peptides presented on HLA class II molecules. A recent
study showed that serum from some pediatric patients
with SLE can induce the generation of class II–bearing
dendritic cells from monocytes, and these cells have a
greatly enhanced ability to present foreign antigen to
CD4 T cells (Blanco et al. 2001). Given recent pro-
gress in understanding the role that apoptotic cells may
have in initiating autoantibody responses in SLE (Cas-
ciola-Rosen et al. 1994; Mevorach et al. 1998), it will
be important to test whether peptides derived from
apoptotic cells and presented on the molecules encoded
by the identified class II risk alleles contribute to SLE
pathogenesis.
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